{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:48:33Z","timestamp":1768438113839,"version":"3.49.0"},"reference-count":110,"publisher":"Baishideng Publishing Group Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Oncol"],"abstract":"<jats:p>Gallbladder cancer (GBC) is a lethal biliary tract malignancy, which is infrequent in most developed countries, but common in many developing countries in specific geographical regions of the world. Non-specific symptoms leading to late diagnosis is one of the primary factors contributing to poor prognosis in GBC. An understanding of the complex relationship between molecular genetics and epidemiological variances in the incidence rates of GBC is thus of utmost importance. Present review summarizes recent updates on population-specific dysregulated genetic expressions in the genesis of GBC, highlighting the pattern of ethno-geographic variations and on advances in targeted therapies conducted till date; points out the lacunae that deserve further attention and suggest possible new directions for future clinical trials in GBC. The review calls for the need of genetic screening of each GBC patients and for more extensive clinical trials on targeted therapies to move towards the goal of personalized medicine, bringing about more favourable survival outcomes.<\/jats:p>","DOI":"10.5306\/wjco.v16.i10.111028","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T01:11:32Z","timestamp":1761268292000},"source":"Crossref","is-referenced-by-count":1,"title":["Global gene expression landscape of gallbladder cancer and advances in targeted therapeutic strategies"],"prefix":"10.5306","volume":"16","author":[{"given":"Sounetra","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunima","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Bandopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusri","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilabja","family":"Sikdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-014-9886-3"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.09.004"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S37357"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/sujhs.sujhs_12_24"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2019.08.13"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144201"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4575-3"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i22.3978"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2024.2345585"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225671"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9649-6"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1726561"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03485-4"},{"key":"B14","unstructured":"Zhou YM, Li YM, Cao N, Feng Y, Zeng F. [Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma]. Ai Zheng 2003; 262-265"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/path.1779"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2005.37.3.171"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02150-w"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4511"},{"key":"B19","unstructured":"Roa I, de Toro G, Schalper K, de Aretxabala X, Churi C, Javle M. Overexpression of the HER2\/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer. Gastrointest Cancer Res 2014; 42-48"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5.285"},{"key":"B21","unstructured":"Hui AM, Li X, Shi YZ, Takayama T, Torzilli G, Makuuchi M. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res 2000; 4272-4277"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2013.14.5.2711"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i5.744"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2010.09.003"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0182-x"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19961115)78:10<2101::aid-cncr10>3.0.co;2-2"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-013-9710-5"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/2320206820968448"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3353\/omp.11.41"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12551"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4103\/jcar.JCar_4_21"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.07.054"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00549-2"},{"key":"B34","unstructured":"Roa I, Araya JC, Shiraishi T, Yatani R, Wistuba I, Villaseca M, de Aretxabala X. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products]. Rev Med Chil 1994; 754-759"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-014-0311-8"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.03.58"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7150\/jca.17898"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae076"},{"key":"B39","doi-asserted-by":"crossref","unstructured":"Espinoza JA, Garc\u00eda P, Bizama C, Roa JC.   Molecular Genetics of Gallbladder Cancer. In: Encyclopedia of Life Sciences. Berlin: Wiley, 2015: 1-7","DOI":"10.1002\/9780470015902.a0024921"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07448-4"},{"key":"B41","unstructured":"Roa JC, Vo Q, Araya JC, Villaseca M, Guzm\u00e1n P, Ibacache GS, de Aretxabala X, Roa I. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma]. Rev Med Chil 2004; 1369-1376"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i47.6396"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(01)00562-6"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600501"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(03)00385-9"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0507-4"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61157-1"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.1999.0763"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S1607-551X(09)70221-9"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000450999"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-126"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/13651820410025110"},{"key":"B53","unstructured":"da Rocha AO, Coutinho LM, Scholl JG, Leboutte LD. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases. Hepatogastroenterology 2004; 1310-1314"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32010"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i21.3425"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2003.50127"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.012963"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.011"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i3.415"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_248_20"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1473_22"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3182a318a9"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2017.69"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1699"},{"key":"B65","unstructured":"Xu ST, Ma YC, Wang CH, Xu Y, Gu GJ. Prognostic and clinicopathologic significance of AEG-1\/MTDH and E-cadherin expression in human gallbladder carcinoma. Int J Clin Exp Pathol 2018; 6025-6031"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-010-0908-6"},{"key":"B67","unstructured":"Puhalla H, Herberger B, Soleiman A, Filipits M, Laengle F, Gruenberger T, Wrba F. E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue. Anticancer Res 2005; 4249-4254"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1159\/000100478"},{"key":"B69","doi-asserted-by":"crossref","unstructured":"Roa E I, Ibacache S G, Melo A A, Morales M E, Villaseca H M, Araya O J, Roa S J, Guzm\u00e1n G P, de Aretxabala U X. Carcinoma subseroso de la ves\u00edcula biliar: expresi\u00f3n del complejo caderina-catenina. Rev m\u00e9d Chile 2002; 1349-1357","DOI":"10.4067\/S0034-98872002001200004"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-67202014000200009"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.03.005"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.272"},{"key":"B73","unstructured":"Zhang Y, Xu J, Xu Z, Wang Y, Wu S, Wu L, Song H, Zhou L. Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance. Int J Clin Exp Pathol 2018; 3618-3627"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/648420"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-023-00913-8"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_134_19"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25895"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/his.13669"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071682"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2020.11.206"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2018.12.008"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.10.004"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00242-5"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02010"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds465"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02566-6"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1356815"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100314"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.4075"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70333-X"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31872"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.02.017"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152670"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000365"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15139"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04161-3"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4110"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00324-2"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0558"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910442"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2019.02.004"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1875-8"},{"key":"B103","unstructured":"Yoon DH, Shin JS, Jin DH, Hong SW, Jung KA, Kim SM, Hong YS, Kim KP, Lee JL, Suh C, Lee JS, Kim TW. The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2. Anticancer Res 2012; 1681-1688"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.881"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91002-2"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11663"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5893"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-4.15476"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9181"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3861"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v16\/i10\/111028.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v16\/i10\/111028.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T01:12:46Z","timestamp":1761268366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v16\/i10\/111028.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":110,"journal-issue":{"issue":"10"},"alternative-id":["111028"],"URL":"https:\/\/doi.org\/10.5306\/wjco.v16.i10.111028","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}